Showing results (1221-1230 of 3,687) with videos related to
Sort By:
Pageof 369
Biochimica Et Biophysica Acta|February 17, 2000
Redox- and pH-dependent association of plastocyanin with lipid bilayers: effect on protein conformation and thermal stabilityS G Taneva, A A Donchev, M I Dimitrov, et al.Journal of Glaucoma|July 10, 2001
Can the specificity of the FDT for glaucoma be improved by confirming abnormal results?J J Khong, P N Dimitrov, J Rait, et al.Free Radical Biology & Medicine|December 25, 2016
Chromatin associated mechanisms in base excision repair - nucleosome remodeling and DNA transcription, two key playersHervé Menoni, Paolo Di Mascio, Jean Cadet, et al.Veterinary Microbiology|December 28, 2016
Newcastle disease vaccines-A solved problem or a continuous challenge?Kiril M Dimitrov, Claudio L Afonso, Qingzhong Yu, et al.AIDS (London, England)|March 1, 1992
Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDSD S Dimitrov, K Hillman, J Manischewitz, et al.Biochemical and Biophysical Research Communications|August 22, 2012
Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodiesWeizao Chen, Yang Feng, Yanping Wang, et al.Cureus|January 30, 2025
Combined Cholecystoenteric Fistula and Choledocholithiasis: A Report of a Rare CaseMila Kovacheva-Slavova, Victor Dimitrov, Plamen Gecov, et al.Vaccine|March 6, 2025
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysisMia Moore, Larissa Anderson, Joshua T Schiffer, et al.Journal of Virology|January 1, 1992
Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoproteinD S Dimitrov, K Hillman, J Manischewitz, et al.Molecular Cancer Therapeutics|May 4, 2012
Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeuticsWeizao Chen, Yang Feng, Qi Zhao, et al.Pageof 369